Traws Pharma Reports Phase 2a Ratutrelvir Results and Completes Tivoxavir Tablet Study
Traws Pharma reported final Phase 2a results for ratutrelvir in COVID-19 and completed a bridging study of its tivoxavir marboxil tablet.Key Highlights:Original SEC Filing: Traws Pharma, Inc. [ TRAW ] - 8-K - Nov. 12, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifyin…